CONTER, VALENTINO

CONTER, VALENTINO  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.021 secondi).
Titolo Tipologia Data di pubblicazione Autori File
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 01 - Articolo su rivista 2022 Biondi, AndreaValsecchi, Maria GraziaRizzari, CarmeloConter, ValentinoCazzaniga, Giovanni +
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 01 - Articolo su rivista 2022 Fazio, GraziaQuadri, ManuelSaitta, ClaudiaPalmi, ChiaraBardini, MichelaSavino, Angela MariaConter, ValentinoRizzari, CarmeloValsecchi, Maria GraziaBiondi, AndreaCazzaniga, Giovanni +
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 01 - Articolo su rivista 2022 Gaipa, GBuracchi, CConter, V +
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 01 - Articolo su rivista 2022 Brivio, EricaCossio, AndreaPrunotto, GiuliaRizzari, CarmeloBiondi, AndreaConter, ValentinoValsecchi, Maria GraziaBalduzzi, Adriana +
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 01 - Articolo su rivista 2022 Rizzari C.Conter V. +
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 01 - Articolo su rivista 2022 Bardini, MichelaValsecchi, Maria GraziaConter, ValentinoBiondi, AndreaCazzaniga, Giovanni +
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2021 Biondi, AndreaValsecchi, Maria GraziaConter, ValentinoBiffi, AlessandraCazzaniga, Giovanni +
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 01 - Articolo su rivista 2021 Fazio G.Bardini M.Grioni A.Quadri M.Palmi C.Conter V.Rizzari C.Valsecchi M. G.Biondi A.Cazzaniga G. +
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study 01 - Articolo su rivista 2021 Colombini A.Pelagatti M. A.Biondi A.Conter V.Rizzari C. +
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 01 - Articolo su rivista 2020 Balduzzi, AdrianaRizzari, CarmeloMelzi, Maria LuisaConter, ValentinoBiondi, Andrea +
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 01 - Articolo su rivista 2020 Leoni, VeronicaConter, ValentinoCazzaniga, GiovanniFazio, GraziaValsecchi, Maria GraziaBiondi, Andrea +
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 01 - Articolo su rivista 2020 Biondi A.Cazzaniga G.Colombini A.Rizzari C.Valsecchi M. G.Conter V. +
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 01 - Articolo su rivista 2019 Biondi, AndreaConter, ValentinoLeoni, VeronicaValsecchi, Maria Grazia +
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 01 - Articolo su rivista 2019 Conter V.Mantovani L. +
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study 01 - Articolo su rivista 2019 Valsecchi M. G.Rizzari C.Biondi A.Conter V. +
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 01 - Articolo su rivista 2018 Rossi, EmanuelaConter, ValentinoBiondi, AndreaMelzi, Maria Luisa +
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 01 - Articolo su rivista 2018 Cazzaniga, GBiondi, AValsecchi, MGConter, V +
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 01 - Articolo su rivista 2018 Biondi, ARizzari, CValsecchi, MGConter, V +
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 01 - Articolo su rivista 2018 Cazzaniga, GLeoni, VFerrari, GMConter, ValentinoValsecchi, MGBiondi, A +
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2018 Galimberti, StefaniaLucenti, AusiliatriceCazzaniga, GiovanniConter, ValentinoBiondi, AndreaValsecchi, Maria Grazia +